Proton pump inhibitors, which are used to control acid reflux, are associated with an increased risk for migraine and other severe headache types, new research showed.
Nearly 18 months after the FDA first acknowledged a national shortage of Adderall, there is now a widespread scarcity of multiple ADHD medications with no end in sight.
Democratic legislators on the House Committee on Oversight and Reform have written a letter to Pfizer, requesting information on how the company is addressing shortages of chemotherapy drugs.
Indian drugmakers aiming to grab a slice of the burgeoning weight-loss treatment sales pie, both at home and abroad, have begun developing their own versions of Novo.
U.S. Senator James Lankford, R-OK, wants CVS to answer for its decision to push its own generic medication rather than allowing customers to also access other low-cost prescription drugs.
The test will help healthcare providers to assess an individual's risk of developing opioid use disorder, offering a new approach to pain management.